Centerwatch News

News and views on the clinical trials industry
  1. PAREXEL International, a global biopharmaceutical services organization, introduced the Perceptive Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp.   Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL’s extensive industry expertise and innovative technology solutions with the power of Microsoft’s […]

    The post PAREXEL launches Perceptive Cloud appeared first on CenterWatch News Online.

  2. CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team. Nick Borders and Rob Estrella join the CluePoints U.S. team to support its impressive global business growth, allowing the company to increase its expanding client base across North […]

    The post CluePoints hires Borders and Estrella appeared first on CenterWatch News Online.

  3. Certara, a global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). The presentation will take place today at the Australasian […]

    The post Certara introduces New Investigator Awards program in Australia appeared first on CenterWatch News Online.

  4. COMPASS Pathways, a healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it is partnering with Worldwide Clinical Trials to conduct a major program of late-stage clinical trials for psilocybin therapy for treatment-resistant depression. Depression is the leading cause of ill-health and disability worldwide, and one of the fastest growing health […]

    The post First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches appeared first on CenterWatch News Online.

  5. Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform for accelerating biotherapeutics discovery across therapeutic areas. “The SuperHuman Platform represents the culmination of a decade of our research in computational library design,” says Jacob […]

    The post Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer appeared first on CenterWatch News Online.

  6. Zilliqa, a highly anticipated blockchain platform based on the technology of sharding, has announced a partnership with GB Blockchain Labs (GBBL), the blockchain arm of Global Brain, one of the largest VC firms in Japan. Zilliqa will also be part of the Global Brain Alliance Forum 2017 to be held in Tokyo on December 8. “We […]

    The post Zilliqa and Global Brain Blockchain Labs partner appeared first on CenterWatch News Online.

  7. Astellas’ Walt Johnston has been elected as chairman of the Illinois Biotechnology Innovation Organization (iBIO) and iBIO Institute Boards of Directors. He succeeds Timothy P Walbert, Horizon Pharma, who served as chairman for the past two years and who will continue to serve on the Board and Executive Committee as Immediate Past Chairman. iBIO, founded […]

    The post Illinois Biotechnology Innovation Organization adds Astellas’ Walt Johnston as chairman appeared first on CenterWatch News Online.

  8. Bioethics International announced the second publication of its Good Pharma Scorecard (GPS), an annual index ranking large pharmaceutical companies and new drugs on their clinical trial transparency, in BMJ Open. Bioethics International is a not-for-profit organization dedicated to raising the bar on ethics, trustworthiness, and patient-centricity in pharma. Two of eleven ranked companies—Johnson & Johnson and […]

    The post Good Pharma Scorecard judges clinical trial transparency appeared first on CenterWatch News Online.

  9. NIH’s All of Us Research Program and the National Library of Medicine (NLM) have teamed up in a landmark effort to advance precision medicine for the benefit of communities through local libraries. Traditional healthcare takes a “one-size fits all” approach, but precision medicine is healthcare that is “tailored to a person based on things unique […]

    The post NIH’s All of Us Research Program, NLM collaborate on outreach efforts through libraries appeared first on CenterWatch News Online.

  10. Despite remarkable improvements in the number of people with healthcare coverage and the vast improvements in many healthcare technologies, not everyone in the nation has benefited equally. Individuals who are low-income, a racial/ethnic minority or who are disadvantaged or disabled typically do not get involved in cutting-edge medical research.  Clinical trial participation is one way […]

    The post Health disparities and clinical trial patient recruitment appeared first on CenterWatch News Online.

Trial Interest Form
1000 characters left

Trial Interest Form

Find out if you may qualify to participate in the Liberty 2 Study
Do I qualify?